AGP Executive Report
Last update: 3 hours agoPAD Care Team Update: Pharmacists are being positioned as key “care extenders” in team-based treatment for peripheral artery disease, helping tackle medication adherence and therapeutic inertia. Birth Tourism Crackdown: The Trump administration tightened visa restrictions aimed at “commercial birth tourism,” with expected added scrutiny at the U.S.-Mexico border. Obesity Drug Race: Novo will pay Hengrui up to $2.6B for a once-weekly obesity pill candidate, signaling renewed competition as GLP-1 leaders face future pricing and generic pressure. FDA/Drug Safety & Approvals: FDA recalls more than 13,000 bottles of blood pressure medication after quality issues, while new product updates include zilucoplan’s autoinjector bioequivalence data and FDA approvals in Parkinson’s. Fraud & Enforcement: DOJ action targets health data security lapses, and a congressional report says CMS fraud-prevention staffing was slashed under Biden. Care Access & Workforce: A caregiver award highlights the growing home-care workforce need, and McKinsey warns AI could force millions of workers to reinvent careers, with healthcare among likely growth areas. Hospital Funding: FEMA is finally releasing $14.5M for an Oregon hospital expansion after delays. Community Health: Baptist Health Floyd and the YMCA launch free Pink Ribbon Pilates classes for breast cancer recovery.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.